Journal of PharmTechNova
Short Name: JPTN• ISSN: 3139-9258• Peer-Reviewed Open Access
Development, Optimization and Evaluation of Naproxen Amorphous ASDs Tablets for Enhanced Solubility and Dissolution Using Hydrophilic Polymers
Abstract
Naproxen is a widely prescribed non-steroidal anti-inflammatory drug (NSAID) belonging to Biopharmaceutical Classification System (BCS) Class II, exhibiting high permeability but poor aqueous solubility, which limits its dissolution rate and oral bioavailability. The present study aimed to develop, optimize, and evaluate amorphous solid dispersions (ASDs) of naproxen using hydrophilic polymers to improve its solubility and dissolution characteristics. Preformulation studies including melting point determination, Fourier Transform Infrared Spectroscopy (FTIR) spectroscopy, differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), UV spectrophotometric analysis, and solubility studies confirmed the identity, purity, and crystalline nature of naproxen. ASDs were prepared by the solvent evaporation method using PVP K30, PEG 6000, HPMC E5, and Poloxamer 188 individually and in combinations. Preliminary screening demonstrated that PVP K30 exhibited the highest solubility enhancement, while the combination of PVP K30 and PEG 6000 showed synergistic improvement. Formulation variables were optimized using response surface methodology (RSM) based on a factorial design with polymer concentration and ethanol volume as independent variables. The optimized formulation (F6) exhibited a production yield of 95.40%, drug content of 86.23%, and 95.68% cumulative drug release within 60 minutes. FTIR and DSC analyses confirmed the absence of significant drug–polymer interactions and indicated successful formation of the ASDs. The optimized dispersion was compressed into tablets that demonstrated acceptable pre- and post-compression characteristics, including hardness, friability, weight variation, and drug content. The tablet formulation released 96.23% of drug within 60 minutes and followed the Korsmeyer–Peppas kinetic model, suggesting anomalous drug release behavior. Accelerated stability studies conducted for three months revealed no significant changes in physicochemical properties or dissolution profile. The findings demonstrate that the developed ASDs tablet effectively enhances the solubility and dissolution of naproxen and represents a promising strategy for improving its oral bioavailability.
Research Keywords & Fields
Export Citation
Generate ready-to-use citations in standard scientific formats
Cited References
- 01.
Aguiar ASN, Felimberti PZ, Duarte VS, Borges LL, Camargo AJ, Perjesi P, et al. Structural Studies of Sodium Counterion on Naproxen: From Solid State to Stability. Adv Phys Res. 2025;4(12). doi: 10.1002/apxr.202500159.
- 02.
2. Kim H, Jang S, Kim IW. Enhanced dissolution of naproxen by combining cocrystallization and eutectic formation. Pharmaceutics. 2021;13(5). doi: 10.3390/pharmaceutics13050618.
- 03.
3. Priyadarshinee S, Umamaheswari S, Ramesh M. Non-steroidal Anti-inflammatory Drug (NSAID) Naproxen-Induced Hepatotoxicity in a Freshwater Fish Labeo rohita. Water Air Soil Pollut. 2023;234(1). doi: 10.1007/s11270-022-06045-2.
- 04.
4. Bárdos V, Szolláth R, Tőzsér P, Mirzahosseini A, Sinkó B, Angi R, et al. Study of the Influence of Pharmaceutical Excipients on the Solubility and Permeability of BCS Class II Drugs. Sci Pharm. 2025;93(2). doi: 10.3390/scipharm93020019.
- 05.
5. Sievens-Figueroa L, Bhakay A, Jerez-Rozo JI, Pandya N, Romañach RJ, Michniak-Kohn B, et al. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications. Int J Pharm. 2012;423(2):496–508. doi: 10.1016/j.ijpharm.2011.12.001.
- 06.
6. Latif MS, Al-Harbi FF, Nawaz A, Rashid SA, Farid A, Mohaini M Al, et al. Formulation and Evaluation of Hydrophilic Polymer Based Methotrexate Patches: In Vitro and In Vivo Characterization. Polymers (Basel). 2022 Mar;14(7):1310. doi: 10.3390/polym14071310.
- 07.
7. Hirun N, Kraisit P, Tantishaiyakul V. Thermosensitive Polymer Blend Composed of Poloxamer 407, Poloxamer 188 and Polycarbophil for the Use as Mucoadhesive In Situ Gel. Polymers (Basel). 2022;14(9). doi: 10.3390/polym14091836.
- 08.
8. Veza I, Spraggon M, Fattah IMR, Idris M. Response surface methodology (RSM) for optimizing engine performance and emissions fueled with biofuel: Review of RSM for sustainability energy transition. Vol. 18, Results in Engineering. 2023. doi: 10.1016/j.rineng.2023.101213.
- 09.
9. Myśliwiec P, Kubit A. Integrated multiobjective optimization of RFSSW parameters for AA2024-T3 using ANOVA machine learning and NSGA II. Sci Rep. 2025;15(1). doi: 10.1038/s41598-025-21941-3.
- 10.
10. Reji M, Kumar R. Response surface methodology (RSM): An overview to analyze multivariate data. Vol. 9, Indian Journal of Microbiology Research. 2022. p. 241–8. doi: 10.18231/j.ijmr.2022.042.
- 11.
11. Zhu Z, Li W, Yin Y, Cao R, Li Z. Differential Scanning Calorimetry Material Studies: Benzil Melting Point Method for Eliminating the Thermal History of DSC. Vol. 2022, Journal of Chemistry. 2022. doi: 10.1155/2022/3423429.
- 12.
12. Arany D, Kőrösi M. Melting point depression of tetrabutylammonium halides in supercritical carbon dioxide. J Supercrit Fluids. 2025;223. doi: 10.1016/j.supflu.2025.106637.
- 13.
13. Ndung S, Nyahanga T, Kinuthia E, Ndiritu A, Kirkok S, Kirimi J. Box-Behnken response surface methodology approach for rifampicin antibiotic fixed-bed optimization studies using macadamia nutshell activated carbon. J Chem Technol. 2025;1(4):173–88. doi: 10.22034/jchemtech.2025.543827.1020.
- 14.
14. Siddiqui FA, Bakshi V. Hydroalcoholic Extraction, Phytoconstituent Profiling by LC-HRMS, and Computational Analysis of Lantana Camara as Potential Glucokinase, Alpha Amylase, Alpha Glucosidase, and DPP-IV Inhibitors. Chem Methodol. 2025;9(12):1189–220. doi: 10.48309/chemm.2025.532981.1980.
- 15.
15. Shukla S, Kumar A, Pathak A, Kumar A, Tripathi K, Singh K. Green Synthesis of Benzimidazole Derivatives : A Sustainable Approach Towards Potent Antimicrobial Agents. J Chem Heal Risks. 2025;15(2):2634–49.
- 16.
16. Mribha M, Sajan M, Ben B. Development and Characterization of Prednisolone Microspheres for the Treatment of Ulcerative Colitis. J Pharm Drug Deliv Res. 2024;13(1). doi: 10.4172/2325-9604.1000255.
- 17.
17. Hess F, Kipping T, Weitschies W, Krause J. Understanding the Interaction of Thermal, Rheological, and Mechanical Parameters Critical for the Processability of Polyvinyl Alcohol-Based Systems during Hot Melt Extrusion. Pharmaceutics. 2024;16(4). doi: 10.3390/pharmaceutics16040472.
- 18.
18. Abbood HK, Hateet RR. Isolation and identificatio of bacterium Pseudomonas aurginosa from burns and evaluation their ability to green synthesis of silver oxide nanoparticles as Antibacterial agent. Med Med Chem. 2024;1(3):129–37. doi: 10.22034/medmedchem.2024.491374.1021.
- 19.
19. Olutayo O, Emmanuel Stella E, Omotola F. Biosynthesis of Iron Oxide Nanoparticles Using Moringa oleifera (Lam) Leaf Extract and Its Anti Plasmodial Studies. Chem Res Tech. 2025;2:99–107. doi: 10.22034/CHEMRESTEC.2025.514186.1043.
- 20.
20. Bhosale PM, Singh M. Optimizing Pharmaceutical Formulations: Advancements in Nanosuspension Pre-Formulation to Enhance Solubility and Bioavailability of Active Agents. Int J Membr Sci Technol. 2023;10(5):804–12. doi: 10.15379/ijmst.v10i5.3546.
- 21.
21. Zampieri FG, Cansian Junior JC, Rodrigues VAP, Lambert JC, Souza T da S de, Oliveira A de FM de, et al. Evaluation of the chemical composition and quantification of capsaicin in oleoresin from peppers of the genus Capsicum spp. DELOS Desarro Local Sosten. 2024;17(54):e1380. 10.55905/rdelosv17.n54-002.
- 22.
22. Sawant MP, Deokar GS. Solubility Profiling and UV-Spectrophotometric Determination of Bioactive Peptides from Ragi. Int J Drug Deliv Technol. 2025;15(3):1265–71. doi: 10.25258/ijddt.15.3.47.
- 23.
23. Muhtadi WK, Firmansyah F, Agustini TT, Rahayu P, Fitriyanti SA, Ulfa R. Validation of Spectrophotometric Method To Quantify Quercetin in the in Vitro Dissolution Study of Self Nano-Emulsifying Drug Delivery System (Snedds). J Farm Sains dan Prakt. 2022;268–73. doi: 10.31603/pharmacy.v8i3.6258.
- 24.
24. Higuchi T, Shih FL, Kimura T, Rytting JH. Solubility determination of barely aqueous‐soluble organic solids. J Pharm Sci. 1979;68(10):1267–72. doi: 10.1002/jps.2600681019.
- 25.
25. Ramadhan S, Omer H. The development of ternary and quaternary ASDs based hydrotropic blends of atorvastatin calcium. Zanco J Med Sci. 2024;28(1):95–110. doi: 10.15218/zjms.2024.010.
- 26.
26. Zhao T, Gu C, Qi J, Liu J, Wang Y, Chen X, et al. In vitro and in vivo performance of ASDs of ursolic acid as a function of polymer type and excipient addition. J Pharm Pharmacol. 2024;76(12):1584–98. doi: 10.1093/jpp/rgae125.
- 27.
27. Krzak A, Bilewicz R. Voltammetric/UV–Vis study of temozolomide inclusion complexes with cyclodextrin derivatives. Bioelectrochemistry. 2020;136. doi: 10.1016/j.bioelechem.2020.107587.
- 28.
28. Sherje AP, Londhe V. Ternary Inclusion Complex of Paliperidone with β-Cyclodextrin and Hydrophilic Polymer for Solubility and Dissolution Enhancement. J Pharm Innov. 2015;10(4):324–34.
- 29.
29. AlQasas N, Johnson D. Determination of Hansen solubility parameters of water-soluble proteins using UV–vis spectrophotometry. Heliyon. 2023;9(11). 10.1016/j.heliyon.2023.e21403.
- 30.
30. Naureen F, Shah Y, Shahnaz, Khuda F. Determination of Saturated Solubility of Mirtazapine Using UV Visible Spectrophotometer. Pharm Commun. 2024;3(1):27–34. doi: 10.55627/pharma.003.001.0799.
- 31.
31. Syed MA, Nahida S. Effect of Sonication on Solubility of Posaconazole in Different Solvents. J PharmTechNova. 2026;01(01):42–8. doi: 10.66220/vagg1j45.
- 32.
32. Podder S, Mukherjee S. Response Surface Methodology (Rsm) As a Tool in Pharmaceutical Formulation Development. Asian J Pharm Clin Res. 2024;17(11):18–25. doi: 10.22159/ajpcr.2024v17i11.52149.
- 33.
33. Alalaiwe A, Alsenaidy MA, Almalki ZS, Fayed MH. Development and Optimization of Sildenafil Orodispersible Mini-Tablets (ODMTs) for Treatment of Pediatric Pulmonary Hypertension Using Response Surface Methodology. Pharmaceutics. 2023;15(3). doi: 10.3390/pharmaceutics15030923.
- 34.
34. Al-Asadi LJAS, Al-Edresi S. Reduction of Time and Cost in Preparation of Nanofibers From Pva, Peo and Hpmc Using Design-Expert® Software. Int J Appl Pharm. 2024;16(4):257–66. doi: 10.22159/ijap.2024v16i4.50022.
- 35.
35. Ulvi H, Yerlikaya MA, Yildiz K. Urban Traffic Mobility Optimization Model: A Novel Mathematical Approach for Predictive Urban Traffic Analysis. Appl Sci. 2024;14(13). doi: 10.3390/app14135873.
- 36.
36. Andrew E, Chidera A, Ekemezie O, Pauline O, Chinedu N, Godswill O. Preparation and Evaluation of Ranitidine Hydrochloride Floating Microspheres. Am J Polym Sci Technol. 2024;10(2):36–46. doi: 10.11648/j.ajpst.20241002.12.
- 37.
37. Anusha V, Umashankar MS, Ganesh Kumar Y. Preformulation Studies of Pitavastatin Calcium– A Primary Step in Further Design of Chronotherapeutic Formulation Synchronized with Circadian Rhythm. Int J Drug Deliv Technol. 2024;14(3):1578–85. doi: 10.25258/ijddt.14.3.46.
- 38.
38. Harahap FS, Oesman R, Fadhillah W, Nasution AP. Penentuan Bulk Density Ultisol Di Lahan Praktek Terbuka Universitas Labuhanbatu. AGROVITAL J Ilmu Pertan. 2021;6(2):56. doi: 10.35329/agrovital.v6i2.1913.
- 39.
39. Daharwal SJ, Prakash Rao S, Singh VK, Chandrakar K, Singh VD. Formulation and characterization of metformin HCl sustained release matrix tablet by using Cassia tora mucilage. Res J Pharm Technol. 2015;8(7):871–9. doi: 10.22270/jddt.v7i6.1520.
- 40.
40. Phanapithakkun S, Yusakul G, Sitthisak C, Plyduang T. Development of tablet formulations containing genistein ASDs optimized using Box-Behnken design for enhanced solubility. J Appl Pharm Sci. 2025;15(4):53–64. doi: 10.7324/japs.2025.222224.
- 41.
41. Bunlung S, Nualnoi T, Issarachot O, Wiwattanapatapee R. Development of raft-forming liquid and chewable tablet formulations incorporating quercetin ASDs for treatment of gastric ulcers. Saudi Pharm J. 2021;29(10):1143–54. doi: 10.1016/j.jsps.2021.08.005.
- 42.
42. El-Helaly SN, Rashad AA. Mirtazapine loaded polymeric micelles for rapid release tablet: A novel formulation—In vitro and in vivo studies. Drug Deliv Transl Res. 2024;14(9):2488–98. doi: 10.1007/s13346-024-01525-w.
- 43.
43. Ali EA, Ahmed OS, Shokri H. A Comparative Quality Study of Selected Authorized and Smuggled Medicines in Aden, Yemen. Electron J Univ Aden Basic Appl Sci. 2023;4(2):178–86. doi: 10.47372/ejua-ba.2023.2.249.
- 44.
44. Zhu W, Long J, Shi M. Release Kinetics Model Fitting of Drugs with Different Structures from Viscose Fabric. Materials (Basel). 2023;16(8). doi: 10.3390/ma16083282.
- 45.
45. Askarizadeh M, Esfandiari N, Honarvar B, Sajadian SA, Azdarpour A. Kinetic Modeling to Explain the Release of Medicine from Drug Delivery Systems. ChemBioEng Rev. 2023;10(6):1006–49. doi: 10.1002/cben.202300027.
Suggested & Related Publications
Articles in related pharmaceutical, biomedical, and life sciences research on PharmSciGate
Launching the Journal of PhytoPharmaceutical and Advanced Chemistry
Siddiqui, Falak Arjumand; Khan, Sharuk L.
Inaugural Message from the Editor It is with great pleasure and a strong sense of responsibility that we welcome readers, authors, reviewers, and members of the scientific community to the Journal of PhytoPharmaceutical and Advanced Chemistry (JPPAC). The launch of this journal marks an important milestone in our collective effort to promote rigorous, ethical, and impactful scientific research at the intersection of phytopharmaceutical sciences and advanced chemical research.
Computational Study of Alkaloids Targeting O-GlcNAc Transferase as Antidiabetic Agents
Pardaev Jamshid; Umida Sadikova
O-GlcNAc Transferase (OGT) plays a pivotal role in glucose metabolism and insulin signaling, making it an attractive therapeutic target for the management of diabetes mellitus. In the present study, a comprehensive in silico approach was employed to investigate the inhibitory potential of selected alkaloids against human OGT, with an emphasis on their binding affinity and pharmacokinetic suitability. Molecular docking analysis was performed using AutoDock Vina to elucidate the interaction patterns between the selected compounds and the active site of OGT. The docking results revealed that berberine exhibited the strongest binding affinity (−7.8 kcal/mol), slightly surpassing that of the native ligand (−7.7 kcal/mol), and formed stable hydrogen bonding and hydrophobic interactions with key catalytic residues such as LYS898, ASN838, and PRO559. In contrast, castanospermine and swainsonine showed comparatively weaker binding affinities, attributed to limited interaction networks within the binding pocket. To further assess the drug development potential of the studied compounds, in silico ADMET analysis was carried out using SwissADME and ADMETlab 3.0. Berberine demonstrated favorable physicochemical properties, superior drug-likeness (highest QED score), and acceptable absorption and toxicity profiles compared to the native ligand and other alkaloids. Although potential cytochrome P450 interactions and moderate bioaccumulation were predicted for berberine, its overall pharmacokinetic profile was well balanced. Collectively, the integrated docking and ADMET results highlight berberine as a promising lead alkaloid targeting OGT, warranting further in vitro and in vivo validation for its potential development as an antidiabetic agent.
Drug repurposing of some US FDA-approved drugs using Binding strength Studies for the Treatment of Methicillin-resistant Staphylococcus aureus Infection
Roy, Dibakar
Methicillin-resistant Staphylococcus aureus (MRSA) is a major multidrug-resistant bacterial pathogen responsible for severe infections worldwide. The increasing resistance of MRSA to conventional antibiotics has created an urgent need for new therapeutic strategies. Drug repurposing of US FDA-approved drugs offers a promising approach to identify alternative anti-MRSA agents while reducing the time and cost associated with traditional drug discovery. In this study, computational Binding strength analysis was performed to evaluate the inhibitory potential of selected compounds against important MRSA target enzymes, including thioredoxin reductase 1, proton motive force protein, and penicillin-binding protein 2a (PBP2a). Molecular docking results demonstrated strong interactions between the ligands and the active sites of the selected enzymes. The native ligand NL_3QFB showed the strongest Binding strength toward thioredoxin reductase 1 with a docking score of −12.2 kcal/mol, while the reference drug Auranofin exhibited −7.8 kcal/mol. For the proton motive force protein, NL_9U6O displayed a docking score of −7.4 kcal/mol, comparable to Niclosamide (−7.5 kcal/mol). Similarly, NL_6Q9N showed strong interaction with PBP2a with a docking score of −8.6 kcal/mol, whereas Afamelanotide showed weaker binding (−1.9 kcal/mol). ADMET analysis indicated acceptable physicochemical and pharmacokinetic properties for several compounds. Overall, the findings suggest that the investigated ligands demonstrate promising Binding capability and favorable drug-like properties against MRSA target enzymes. However, further experimental validation is required to confirm their therapeutic potential.
Full-Text Access
Journal of PharmTechNova
A platform for pioneering research in novel pharmaceutical technology, biotechnology, drug delivery, clinical translation, and computational design.
This peer-reviewed publication is indexed directly from the publisher repository adhering to Open Archives Initiative (OAI-PMH) metadata standards, Crossref DOI schema, and Google Scholar Highwire Press protocols.
